Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 372 of 6351
-
Major trial to determine best drug for rare autoimmune disease
Disease control Not yet recruitingNeuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune condition that mainly affects the eyes and spinal cord, causing serious symptoms such as vision loss, paralysis, and severe pain. This trial compares the effectiveness and safety of five medications commonly used…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Magic mushroom compound tested for tough depression and addiction
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if a single dose of psilocybin (5mg Vs 10mg Vs 25mg) alongside psychotherapy is safe and can help treat treatment resistant depression (TRD) with co-occurring substance use disorder (SUD) in veterans and first responders. We seek to ans…
Phase 1/2 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New hope for Hard-to-Treat prostate cancer: drug combo trial launches
Disease control Not yet recruitingThe purpose of this study is to find out whether mevrometostat in combination with enzalutamide delays cancer progression in people with metastatic castration-resistant prostate cancer (mCRPC) who have previously received enzalutamide, darolutamide, or apalutamide in the metastat…
Phase 2 • Sponsor: Prostate Cancer Clinical Trials Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Herbal cocktail aims to boost brain bleed recovery in 902-Patient trial
Disease control Not yet recruitingThis multicenter, prospective, double-blind, randomized controlled trial will enroll 902 non-surgical patients with supratentorial hypertensive intracerebral hemorrhage who meet the traditional Chinese medicine syndrome criteria of Qi deficiency with blood stasis and toxin-induce…
Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New radiation technique aims to shield airways and preserve lung function
Symptom relief Not yet recruitingDecreased respiratory function is a common side effect experienced by non-small cell lung cancer (NSCLC) patients who receive radiation therapy. In current clinical practice when treating cancerous lesions in the lung, it is not standard to explicitly try and avoid excessive radi…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New drugs aim to slow muscle decline in duchenne muscular dystrophy
Disease control Not yet recruitingThis is a study of investigational medicines ENTR-601-44 and ENTR-601-45 designed to evaluate the long-term safety and tolerability of study drugs in participants with Duchenne muscular dystrophy (DMD). The investigational medicines are currently being investigated in multiple a…
Phase 2 • Sponsor: Entrada Therapeutics, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Herbal formula may help HIV patients whose immune systems Don't fully recover
Disease control Not yet recruitingThis pragmatic randomized controlled trial evaluates whether Qiling Yiqi Tablets combined with antiretroviral therapy (ART) improves immune reconstitution in people with HIV who meet criteria for immune reconstitution failure and lung-spleen qi deficiency syndrome. Eligible parti…
Sponsor: Beijing University of Chinese Medicine • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Gut bacteria may lift depression — a trial puts it to the test
Disease control Not yet recruitingIBNI617 is a live biotherapeutic product(LBP). This is a randomized, double-blind, placebo-controlled, parallel-group Phase II clinical trial to evaluate the efficacy and safety of IBNI617 in adult patients with major depressive disorder (MDD). Eligible participants will be rand…
Sponsor: IBIOME BIOTECHNOLOGY CO., LTD • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can an experimental pill boost chemotherapy's power against stubborn uterine cancer?
Disease control Not yet recruitingThe purpose of this study is to evaluate whether treatment with the investigational drug OK-1 in combination with paclitaxel can reduce tumor burden in patients with advanced or recurrent endometrial cancer (A/R-EC).
Phase 2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can mindfulness curb relapse and burnout in peer recovery coaches?
Disease control Recruiting nowAdapt and test the effectiveness of MBRP for substance use peer workers compared to a standard of care (referral to 12-step) control condition on substance use, relapse risk, and burnout among peers in a pilot hybrid type 1 trial. The goal of this clinical trial is to learn if M…
Sponsor: University of Texas at Austin • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a 3D virtual world rehab your heart?
Disease control Not yet recruitingThe purpose of this research is to compare health outcomes and participation between a virtual world cardiac rehabilitation (Destination Cardiac Rehab) program and the standard of care Center-based Cardiac Rehabilitation program. Destination Cardiac Rehab, developed with input fr…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
AI vs. human touch: which rehab wins for back pain?
Disease control Not yet recruitingLow back dysfunction is one of the most common musculoskeletal disorders and is associated with pain, disability, and reduced quality of life. Artificial intelligence (AI) has emerged as a promising tool to support personalized rehabilitation by improving exercise prescription, m…
Sponsor: Cairo University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
A 10-Day h. pylori cure? new trial tests a streamlined approach
Disease control Not yet recruitingBackground: Helicobacter pylori (H. pylori) infection affects approximately 50% of the global population and is closely associated with chronic gastritis, peptic ulcer disease, and gastric cancer. Eradication of H. pylori can reduce the overall risk of gastric cancer by 39%. Cur…
Phase 4 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
A break from seizure pills: could less medication mean better living?
Disease control Recruiting nowThe main purpose of this study is to understand the effects of continuing versus discontinuing antiseizure medications after a period of seizure-freedom. Physician guidelines endorse that after a period of seizure-freedom, the risk of another seizure may be low enough to allow pa…
Phase 4 • Sponsor: University of Michigan • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
Prevention Not yet recruitingOvarian cancer is a deadly disease that is hard to detect early and difficult to treat. Research shows that most ovarian cancers actually start in the fallopian tubes, not the ovaries. Removing the fallopian tubes (a procedure called salpingectomy) can lower the risk of ovarian c…
Early phase 1 • Sponsor: St. Joseph's Healthcare Hamilton • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
Could a vaccine help fight Hard-to-Treat cancers?
Disease control Recruiting nowThis study aims to determine the safety and maximum tolerated dose (MTD) of YMN-136 vaccine through a dose escalation trial, and to investigate whether YMN-136 vaccine can assist in the treatment of patients with advanced hepatobiliary and pancreatic malignancies.
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could a platelet booster keep chemotherapy on track for breast cancer patients?
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of Romiplostim N01 for Injection administered as secondary prophylaxis in breast cancer patients with chemotherapy-induced thrombocytopenia (CIT).
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Soothing sounds: a simple audio may help Low-Birth-Weight babies thrive
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if listening to a relaxation audiorecording during breastfeeding improves breastfeeding and infant outcomes and maternal well-being in a low-income country setting. The main questions it aims to answer are: * Does listening to a relaxa…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
A family voice and a glimpse of home: a new weapon against ICU delirium?
Prevention Not yet recruitingThe goal of this nonrandomized, quasi-experimental clinical trial is to evaluate whether an intelligent audiovisual intervention can prevent delirium and reduce delirium severity, agitation, and pain among adults aged 55 years or older admitted to an emergency intensive care unit…
Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Could goat milk formula soothe fussy Babies' tummies?
Symptom relief Not yet recruitingInfant gastrointestinal discomfort is common in early life and can affect feeding, sleep, and overall well-being. Goat milk formula, due to its unique protein composition and smaller fat globules, may be easier to digest and potentially improve gastrointestinal tolerance in infan…
Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC